Does a hyaluronic acid serum with peptides work?

No trial has tested this exact product

Short answer: we found no clinical trial of a single serum that combines hyaluronic acid and peptides. The evidence covers each ingredient on its own, and for peptides it is thin. Any extra benefit from the combination is untested, not proven. We also found no position from the AAD or FDA on either ingredient. For the basics on the ingredient, see our hyaluronic acid guide.

Hyaluronic acid: moisture yes, miracles no

Bottom line: topical hyaluronic acid has some support for hydrating dry skin, but the strongest trial is small. In a double-blind trial of 36 older adults with dry skin, a low-molecular-weight HA lotion raised skin capacitance more than a high-molecular-weight version or vehicle at week 4. Water loss and symptom scores did not differ between arms.

The smaller-molecule idea deserves a closer look. The authors note that the belief that low-molecular-weight HA penetrates better and hydrates more has had little clinical testing. This trial is one of the few to test it, so the claim remains weakly supported.

Other topical data are less rigorous. An open-label micronized-HA cream study reported hydration gains of 24% at 4 weeks and 38.9% at 12 weeks, but it had no control group and no blinding. A multicenter study of a topical HA serum reported significant improvements in fine lines, texture and hydration. We could not verify its sample size, control arm or sponsorship from the text we retrieved.

Peptides: the least-proven half of the bottle

Bottom line: the peptide evidence is mostly oral, and topical data are sparse. A meta-analysis of oral and topical peptide trials pooled 19 RCTs with 1,341 participants. The pooled wrinkle effect was modest, and the authors attribute most of it to oral polypeptides. Elasticity results were inconsistent.

Topical is the weaker branch. A systematic review of topical exosome and peptide therapies found nine topical-peptide studies, three of which reported improvements in fine lines and wrinkles. The authors describe a paucity of topical-peptide data, especially since 2010, and the review itself is rated Level 3 evidence.

On safety, peptides were generally well tolerated in the reviewed trials, with few reported adverse events. That is reassuring, but it is not proof that a serum works.

Don't mistake oral HA for a serum result

Bottom line: the oral HA trials are interesting, but they do not transfer to a bottle. A 12-week RCT of 150 healthy adults tested 1.8 MDa oral sodium hyaluronate at 60 or 120 mg/day against placebo. The 120 mg dose improved hydration and elasticity and reduced water loss, sebum and periorbital wrinkle depth compared with placebo.

That is a supplement study. It says nothing direct about what a topical serum does on your skin, so if a product borrows this result in its marketing, read it as context, not evidence.

How to judge the bottle on the shelf

Bottom line: treat 'clinically proven' as a question, not a credential. A critical review of skin-aging interventions found small samples, short follow-up, subjective outcomes, weak controls and frequent industry sponsorship across the field, including HA.

• Look for the study design. Was there a control arm, and was the study blinded?
• Ask for the numbers. The sources we reviewed did not report HA percentage, peptide type, concentration or vehicle.
• Match the claim to the study. Cosmetics in the US are not FDA-approved for efficacy, so a claim should line up with a cited study of comparable design.